On September 1, 2026 NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, reported that the Company will participate in the Morgan Stanley 24th Annual Global Healthcare Conference, which is being held Sept. 14–16, 2026, in New York, NY.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Management’s fireside chat is scheduled for Tuesday, Sept. 15, at 7:45 am ET. A live audio webcast of the session can be accessed here.

An archived replay of the session will be available on the Investor Relations section of the Company’s website at ir.neogenomics.com.

(Press release, NeoGenomics Laboratories, SEP 1, 2026, View Source [SID1234670506])